Engineering copper homeostasis for microenvironment-adaptive therapy in inflammation-driven disorders

Authors: Ding, Feixiang; Liu, Junyan; Liu, Min; Huang, Hong; Tang, Huifang; Zhong, Jun; Liu, Chong; Liu, Zhaoqian

Source journal: Bioactive materials (2027-04-01)

DOI: 10.1016/j.bioactmat.2026.09.047

Abstract

Inflammation-driven disorders (IDDs) arise from distinct initiating events, yet many persist because immune activation, oxidative and metabolic stress, regulated cell death, and tissue remodeling form self-reinforcing local niches. Copper connects these processes through its roles as a cuproenzyme cofactor, redox-active species and dynamically trafficked regulatory metal. Its therapeutic significance, however, is determined by disease stage, cell type, subcellular distribution and chemical state. Copper deficiency, excess or mislocalization may therefore be adaptive, protective or pathogenic in different contexts. This review develops a disease- and copper-state-specific framework that links copper homeostasis to therapeutic platform design. We first examine inflammation-associated remodeling of copper trafficking and compare representative copper states in autoimmune joint disease, metabolic inflammation, fibrosis, inflammation-associated cancer and infection-associated tissue repair. We then critically evaluate copper-dependent and copper-sensitive mechanisms governing inflammatory mediator availability, immune-cell programming and checkpoint regulation, regulated cell death, angiogenesis and stromal remodeling, while distinguishing direct mechanistic evidence from model-dependent inference. Building on this analysis, we compare pharmacological modulators with nanocarriers, copper-containing active materials and local copper-sequestering platforms that implement copper chelation or sequestration, controlled copper delivery or release, intracellular redistribution, and catalytic activation or nanozyme-like redox regulation. We further outline how pathological copper pools, activation cues, release kinetics, speciation, biodistribution and target engagement should be measured so that precision is demonstrated rather than inferred from material composition. This framework positions copper modulation as a context-specific complement to existing therapy and defines the mechanistic, analytical and translational evidence required for microenvironment-adaptive treatment of IDDs.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.